{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T21:21:57Z","timestamp":1743110517255,"version":"3.40.3"},"publisher-location":"Cham","reference-count":122,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030809621"},{"type":"electronic","value":"9783030809621"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-3-030-80962-1_299-1","type":"book-chapter","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T16:18:25Z","timestamp":1676045905000},"page":"1-43","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nanotheranostics: The Afterglow for Cancer Immunotherapy"],"prefix":"10.1007","author":[{"given":"C\u00e1tia","family":"Domingues","sequence":"first","affiliation":[]},{"given":"Mar\u00edlia","family":"Dourado","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Veiga","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Figueiras","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,2,11]]},"reference":[{"doi-asserted-by":"crossref","unstructured":"Abadjian MCZ, Choi J, Anderson CJ (2016) Nanoparticles for PET imaging of tumors and cancer metastasis. In: Design and applications of nanoparticles in biomedical imaging. Springer International Publishing, Switzerland, pp 229\u2013255","key":"299-1_CR1","DOI":"10.1007\/978-3-319-42169-8_11"},{"key":"299-1_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.7150\/ntno.50860","volume":"5","author":"O Abousaway","year":"2021","unstructured":"Abousaway O, Rakhshandehroo T, Van den Abbeele AD et al (2021) Noninvasive imaging of cancer immunotherapy. Nano 5:90\u2013112. https:\/\/doi.org\/10.7150\/ntno.50860","journal-title":"Nano"},{"key":"299-1_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1089\/ten.teb.2011.0230","volume":"17","author":"A Appel","year":"2011","unstructured":"Appel A, Anastasio MA, Brey EM (2011) Potential for imaging engineered tissues with X-ray phase contrast. Tissue Eng \u2013 Part B Rev 17:321\u2013330. https:\/\/doi.org\/10.1089\/ten.teb.2011.0230","journal-title":"Tissue Eng \u2013 Part B Rev"},{"doi-asserted-by":"publisher","unstructured":"Baranov PV, Atkins JF (2022) Immune cells alter genetic decoding in cancer. Nature. https:\/\/doi.org\/10.1038\/d41586-022-00637-y","key":"299-1_CR4","DOI":"10.1038\/d41586-022-00637-y"},{"key":"299-1_CR5","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K et al (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24:541\u2013550. https:\/\/doi.org\/10.1038\/s41591-018-0014-x","journal-title":"Nat Med"},{"key":"299-1_CR6","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.3390\/cells9092102","volume":"9","author":"E Bockamp","year":"2020","unstructured":"Bockamp E, Rosigkeit S, Siegl D, Schuppan D (2020) Nano-enhanced cancer immunotherapy: immunology encounters nanotechnology. Cell 9:2102","journal-title":"Cell"},{"key":"299-1_CR7","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/453840a","volume":"453","author":"D Butler","year":"2008","unstructured":"Butler D (2008) Translational research: crossing the valley of death. Nature 453:840\u2013842","journal-title":"Nature"},{"key":"299-1_CR8","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.3390\/nano11081950","volume":"11","author":"R Canese","year":"2021","unstructured":"Canese R, Vurro F, Marzola P (2021) Iron oxide nanoparticles as theranostic agents in cancer immunotherapy. Nano 11:1950. https:\/\/doi.org\/10.3390\/nano11081950","journal-title":"Nano"},{"unstructured":"Chandra G, Srivastava D (2017) Nanomedicine market share, size and global outlook by 2023 | AMR. Allied Mark Res. A01691. https:\/\/www.alliedmarketresearch.com\/nanomedicine-market. Accessed 14 Dec 2021","key":"299-1_CR9"},{"key":"299-1_CR10","doi-asserted-by":"publisher","first-page":"1907146","DOI":"10.1002\/smll.201907146","volume":"16","author":"M Chang","year":"2020","unstructured":"Chang M, Hou Z, Wang M et al (2020) Cu2MoS4\/Au heterostructures with enhanced catalase-like activity and photoconversion efficiency for primary\/metastatic tumors eradication by phototherapy-induced immunotherapy. Small 16:1907146. https:\/\/doi.org\/10.1002\/smll.201907146","journal-title":"Small"},{"key":"299-1_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen DS, Mellman I (2013) Oncology meets immunology: the cancer-immunity cycle. Immunity 39:1\u201310","journal-title":"Immunity"},{"key":"299-1_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/natrevmats.2017.24","volume":"2","author":"H Chen","year":"2017","unstructured":"Chen H, Zhang W, Zhu G et al (2017) Rethinking cancer nanotheranostics. Nat Rev Mater 2:1\u201318","journal-title":"Nat Rev Mater"},{"key":"299-1_CR13","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1021\/acs.nanolett.1c00818","volume":"21","author":"C Chen","year":"2021","unstructured":"Chen C, Song M, Du Y et al (2021) Tumor-associated-macrophage-membrane-coated nanoparticles for improved photodynamic immunotherapy. Nano Lett 21:5522\u20135531. https:\/\/doi.org\/10.1021\/acs.nanolett.1c00818","journal-title":"Nano Lett"},{"key":"299-1_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jcis.2022.01.099","volume":"615","author":"L Cheng","year":"2022","unstructured":"Cheng L, Sang D, Zhao F et al (2022) Magnetic resonance\/infrared dual-modal imaging-guided synergistic Photothermal\/photodynamic therapy Nanoplatform based on Cu1.96S-Gd@FA for precision cancer Theranostics. J Colloid Interface Sci 615:95\u2013109. https:\/\/doi.org\/10.1016\/j.jcis.2022.01.099","journal-title":"J Colloid Interface Sci"},{"key":"299-1_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrc3672","volume":"14","author":"KF Chu","year":"2014","unstructured":"Chu KF, Dupuy DE (2014) Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer 14:199\u2013208","journal-title":"Nat Rev Cancer"},{"key":"299-1_CR16","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1016\/j.apsb.2021.03.023","volume":"11","author":"NB Day","year":"2021","unstructured":"Day NB, Wixson WC, Shields CW (2021) Magnetic systems for cancer immunotherapy. Acta Pharm Sin B 11:2172\u20132196","journal-title":"Acta Pharm Sin B"},{"key":"299-1_CR17","doi-asserted-by":"publisher","first-page":"12096","DOI":"10.1021\/acsnano.8b05292","volume":"12","author":"G Deng","year":"2018","unstructured":"Deng G, Sun Z, Li S et al (2018) Cell-membrane immunotherapy based on natural killer cell membrane coated nanoparticles for the effective inhibition of primary and Abscopal tumor growth. ACS Nano 12:12096\u201312108. https:\/\/doi.org\/10.1021\/acsnano.8b05292","journal-title":"ACS Nano"},{"key":"299-1_CR18","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.3389\/fimmu.2019.02965","volume":"10","author":"P Dobosz","year":"2019","unstructured":"Dobosz P, Dzieci\u0105tkowski T (2019) The intriguing history of cancer immunotherapy. Front Immunol 10:2965","journal-title":"Front Immunol"},{"key":"299-1_CR19","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1021\/acs.molpharmaceut.9b00945","volume":"16","author":"C Domingues","year":"2019","unstructured":"Domingues C, Alvarez-Lorenzo C, Concheiro A et al (2019) Nanotheranostic Pluronic-like polymeric micelles: shedding light into the dark shadows of Tumors. Mol Pharm 16:4757\u20134774. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00945","journal-title":"Mol Pharm"},{"doi-asserted-by":"publisher","unstructured":"Domingues C, Santos A, Alvarez-Lorenzo C et al (2022) Where is nano today and where is it headed? A review of nanomedicine and the dilemma of nanotoxicology. ACS Nano. https:\/\/doi.org\/10.1021\/acsnano.2c00128","key":"299-1_CR20","DOI":"10.1021\/acsnano.2c00128"},{"key":"299-1_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119659","volume":"230","author":"X Dong","year":"2020","unstructured":"Dong X, Yang A, Bai Y et al (2020) Dual fluorescence imaging-guided programmed delivery of doxorubicin and CpG nanoparticles to modulate tumor microenvironment for effective chemo-immunotherapy. Biomaterials 230:119659. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119659","journal-title":"Biomaterials"},{"key":"299-1_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc1252","volume":"4","author":"G Dranoff","year":"2004","unstructured":"Dranoff G (2004) Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4:11\u201322","journal-title":"Nat Rev Cancer"},{"doi-asserted-by":"publisher","unstructured":"Forte E, Fiorenza D, Torino E et al (2020) Radiolabeled PET\/MRI nanoparticles for tumor imaging. J Clin Med 9:89. https:\/\/doi.org\/10.3390\/jcm9010089","key":"299-1_CR23","DOI":"10.3390\/jcm9010089"},{"key":"299-1_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118796","volume":"572","author":"EG Fuller","year":"2019","unstructured":"Fuller EG, Scheutz GM, Jimenez A et al (2019) Theranostic nanocarriers combining high drug loading and magnetic particle imaging. Int J Pharm 572:118796. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118796","journal-title":"Int J Pharm"},{"key":"299-1_CR25","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.7150\/thno.33574","volume":"9","author":"K Gao","year":"2019","unstructured":"Gao K, Tu W, Yu X et al (2019) W-doped TiO2 nanoparticles with strong absorption in the NIR-II window for photoacoustic\/CT dual-modal imaging and synergistic thermoradiotherapy of tumors. Theranostics 9:5214\u20135226. https:\/\/doi.org\/10.7150\/thno.33574","journal-title":"Theranostics"},{"unstructured":"GBI Research (2018) Cancer immunotherapies drugs market set for substantial growth. Pharm Technol https:\/\/www.pharmaceutical-technology.com\/research-reports\/cancer-immunotherapies-drugs-market\/. Accessed 16 Mar 2022","key":"299-1_CR26"},{"key":"299-1_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.addr.2016.08.001","volume":"113","author":"S Goel","year":"2017","unstructured":"Goel S, England CG, Chen F, Cai W (2017) Positron emission tomography and nanotechnology: a dynamic duo for cancer theranostics. Adv Drug Deliv Rev 113:157\u2013176","journal-title":"Adv Drug Deliv Rev"},{"doi-asserted-by":"publisher","unstructured":"Grandl S, Willner M, Herzen J et al (2013) Evaluation of phase-contrast CT of breast tissue at conventional X-ray sources - presentation of selected findings. Z Med Phys 23:212\u2013221. https:\/\/doi.org\/10.1016\/j.nano.2011.01.010","key":"299-1_CR28","DOI":"10.1016\/j.nano.2011.01.010"},{"key":"299-1_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12:31\u201346","journal-title":"Cancer Discov"},{"key":"299-1_CR30","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RAA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"doi-asserted-by":"publisher","unstructured":"Healy S, Bakuzis AF, Goodwill PW et al (2022) Clinical magnetic hyperthermia requires integrated magnetic particle imaging. WIREs Nanomedicine and Nanobiotechnology e1779. https:\/\/doi.org\/10.1002\/wnan.1779","key":"299-1_CR31","DOI":"10.1002\/wnan.1779"},{"key":"299-1_CR32","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.it.2019.08.003","volume":"40","author":"DA Horwitz","year":"2019","unstructured":"Horwitz DA, Fahmy TM, Piccirillo CA, La Cava A (2019) Rebalancing immune homeostasis to treat autoimmune diseases. Trends Immunol 40:888\u2013908","journal-title":"Trends Immunol"},{"key":"299-1_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmatsci.2020.100685","volume":"114","author":"JJ Hu","year":"2020","unstructured":"Hu JJ, Lei Q, Zhang XZ (2020) Recent advances in photonanomedicines for enhanced cancer photodynamic therapy. Prog Mater Sci 114:100685","journal-title":"Prog Mater Sci"},{"key":"299-1_CR34","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1021\/acs.chemrev.0c00779","volume":"121","author":"M Izci","year":"2021","unstructured":"Izci M, Maksoudian C, Manshian BB, Soenen SJ (2021) The use of alternative strategies for enhanced nanoparticle delivery to solid tumors. Chem Rev 121:1746\u20131803","journal-title":"Chem Rev"},{"key":"299-1_CR35","doi-asserted-by":"publisher","first-page":"8581","DOI":"10.3390\/ijms23158581","volume":"23","author":"I Jarak","year":"2022","unstructured":"Jarak I, Silva I, Domingues C et al (2022) Nanofiber carriers of therapeutic load: current trends. Int J Mol Sci 23:8581. https:\/\/doi.org\/10.3390\/ijms23158581","journal-title":"Int J Mol Sci"},{"key":"299-1_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.addr.2020.06.012","volume":"167","author":"Y Ji","year":"2020","unstructured":"Ji Y, Jones C, Baek Y et al (2020) Near-infrared fluorescence imaging in immunotherapy. Adv Drug Deliv Rev 167:121\u2013134","journal-title":"Adv Drug Deliv Rev"},{"key":"299-1_CR37","doi-asserted-by":"publisher","first-page":"434","DOI":"10.7150\/thno.67300","volume":"12","author":"B Ji","year":"2022","unstructured":"Ji B, Wei M, Yang B (2022) Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy. Theranostics 12:434\u2013458","journal-title":"Theranostics"},{"key":"299-1_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.canlet.2021.06.028","volume":"520","author":"P Jin","year":"2021","unstructured":"Jin P, Li J, Meng Y et al (2021) PET\/CT metabolic patterns in systemic immune activation: a new perspective on the assessment of immunotherapy response and efficacy. Cancer Lett 520:91\u201399","journal-title":"Cancer Lett"},{"key":"299-1_CR39","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41571-022-00600-w","volume":"19","author":"DB Johnson","year":"2022","unstructured":"Johnson DB, Nebhan CA, Moslehi JJ, Balko JM (2022) Immune-checkpoint inhibitors: long-term implications of toxicity. Nat Rev Clin Oncol 19:254\u2013267","journal-title":"Nat Rev Clin Oncol"},{"key":"299-1_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02587.x","volume":"121","author":"R Kim","year":"2007","unstructured":"Kim R, Emi M, Tanabe K (2007) Cancer immunoediting from immune surveillance to immune escape. Immunology 121:1\u201314. https:\/\/doi.org\/10.1111\/j.1365-2567.2007.02587.x","journal-title":"Immunology"},{"doi-asserted-by":"publisher","unstructured":"Kim J, Chhour P, Hsu J et al (2017) Use of nanoparticle contrast agents for cell tracking with computed tomography. Bioconjug Chem 28:1581\u20131597. https:\/\/doi.org\/10.1016\/j.nano.2011.01.010","key":"299-1_CR41","DOI":"10.1016\/j.nano.2011.01.010"},{"key":"299-1_CR42","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jss.2018.07.015","volume":"232","author":"MP Lanfranca","year":"2018","unstructured":"Lanfranca MP, Lazarus J, Shao X et al (2018) Tracking macrophage infiltration in a mouse model of pancreatic cancer with the positron emission tomography tracer [11C]PBR28. J Surg Res 232:570\u2013577. https:\/\/doi.org\/10.1016\/j.jss.2018.07.015","journal-title":"J Surg Res"},{"key":"299-1_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9113483","volume":"9","author":"D Lang","year":"2020","unstructured":"Lang D, Wahl G, Poier N et al (2020) Impact of pet\/ct for assessing response to immunotherapy \u2013 a clinical perspective. J Clin Med 9:1\u201322","journal-title":"J Clin Med"},{"key":"299-1_CR44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.coi.2019.11.004","volume":"62","author":"SB Larsen","year":"2020","unstructured":"Larsen SB, Cowley CJ, Fuchs E (2020) Epithelial cells: liaisons of immunity. Curr Opin Immunol 62:45\u201353","journal-title":"Curr Opin Immunol"},{"key":"299-1_CR45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41568-020-00323-z","volume":"21","author":"RC Larson","year":"2021","unstructured":"Larson RC, Maus MV (2021) Recent advances and discoveries in the mechanisms and functions of CAR T cells. Nat Rev Cancer 21:145\u2013161","journal-title":"Nat Rev Cancer"},{"key":"299-1_CR46","doi-asserted-by":"publisher","first-page":"10549","DOI":"10.1002\/anie.201304026","volume":"52","author":"SB Lee","year":"2013","unstructured":"Lee SB, Kim HL, Jeong H-J et al (2013) Mesoporous silica nanoparticle Pretargeting for PET imaging based on a rapid bioorthogonal reaction in a living body. Angew Chemie Int Ed 52:10549\u201310552. https:\/\/doi.org\/10.1002\/anie.201304026","journal-title":"Angew Chemie Int Ed"},{"key":"299-1_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/am.2016.80","volume":"8","author":"SB Lee","year":"2016","unstructured":"Lee SB, Ahn SB, Lee SW et al (2016) Radionuclide-embedded gold nanoparticles for enhanced dendritic cell-based cancer immunotherapy, sensitive and quantitative tracking of dendritic cells with PET and cerenkov luminescence. NPG Asia Mater 8:1\u201310. https:\/\/doi.org\/10.1038\/am.2016.80","journal-title":"NPG Asia Mater"},{"key":"299-1_CR48","doi-asserted-by":"publisher","first-page":"12680","DOI":"10.1002\/anie.201906288","volume":"58","author":"J Li","year":"2019","unstructured":"Li J, Cui D, Huang J et al (2019) Organic semiconducting pro-nanostimulants for near-infrared photoactivatable cancer immunotherapy. Angew Chemie Int Ed 58:12680\u201312687. https:\/\/doi.org\/10.1002\/anie.201906288","journal-title":"Angew Chemie Int Ed"},{"doi-asserted-by":"publisher","unstructured":"Li C, Zhao L, Jia L et al (2022) 68Ga-labeled dendrimer-entrapped gold nanoparticles for PET\/CT dual-modality imaging and immunotherapy of tumors. J Mater Chem B. https:\/\/doi.org\/10.1039\/D2TB00378C","key":"299-1_CR49","DOI":"10.1039\/D2TB00378C"},{"key":"299-1_CR50","doi-asserted-by":"publisher","first-page":"5265","DOI":"10.7150\/thno.58390","volume":"11","author":"YT Liu","year":"2021","unstructured":"Liu YT, Sun ZJ (2021) Turning cold tumors into hot tumors by improving T-cell infiltration. Theranostics 11:5265\u20135286","journal-title":"Theranostics"},{"key":"299-1_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2019.123979","volume":"385","author":"H Liu","year":"2020","unstructured":"Liu H, Yang Q, Guo W et al (2020) CoWO4-x-based nanoplatform for multimode imaging and enhanced photothermal\/photodynamic therapy. Chem Eng J 385:123979. https:\/\/doi.org\/10.1016\/j.cej.2019.123979","journal-title":"Chem Eng J"},{"key":"299-1_CR52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12951-021-00862-z","volume":"19","author":"N Liu","year":"2021","unstructured":"Liu N, Chen X, Sun X et al (2021a) Persistent luminescence nanoparticles for cancer theranostics application. J. Nanobiotechnol 19:113","journal-title":"J. Nanobiotechnol"},{"key":"299-1_CR53","doi-asserted-by":"publisher","first-page":"10097","DOI":"10.1039\/d1sc02203b","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Mo F, Hu J et al (2021b) Precision photothermal therapy and photoacoustic imaging byin situactivatable thermoplasmonics. Chem Sci 12:10097\u201310105. https:\/\/doi.org\/10.1039\/d1sc02203b","journal-title":"Chem Sci"},{"key":"299-1_CR54","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.3389\/fphar.2022.905078","volume":"13","author":"Y Ma","year":"2022","unstructured":"Ma Y, Xiao F, Lu C, Wen L (2022) Multifunctional Nanosystems powered photodynamic immunotherapy. Front Pharmacol 13:1720. https:\/\/doi.org\/10.3389\/fphar.2022.905078","journal-title":"Front Pharmacol"},{"key":"299-1_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-02128-1","volume":"12","author":"F Marofi","year":"2021","unstructured":"Marofi F, Motavalli R, Safonov VA et al (2021) CAR T cells in solid tumors: challenges and opportunities. Stem Cell Res Ther 12:1\u201316","journal-title":"Stem Cell Res Ther"},{"key":"299-1_CR56","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s43018-022-00347-4","volume":"3","author":"MV Maus","year":"2022","unstructured":"Maus MV (2022) A decade of CAR T cell evolution. Nat Cancer 3:270\u2013271","journal-title":"Nat Cancer"},{"key":"299-1_CR57","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3389\/fimmu.2020.01067","volume":"11","author":"CE McCarthy","year":"2020","unstructured":"McCarthy CE, White JM, Viola NT, Gibson HM (2020) In vivo imaging technologies to monitor the immune system. Front Immunol 11:1067","journal-title":"Front Immunol"},{"key":"299-1_CR58","doi-asserted-by":"publisher","first-page":"6363","DOI":"10.1021\/acsnano.5b01939","volume":"9","author":"R Meir","year":"2015","unstructured":"Meir R, Shamalov K, Betzer O et al (2015) Nanomedicine for cancer immunotherapy: tracking cancer-specific T-cells in vivo with gold nanoparticles and CT imaging. ACS Nano 9:6363\u20136372. https:\/\/doi.org\/10.1021\/acsnano.5b01939","journal-title":"ACS Nano"},{"key":"299-1_CR59","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bbcan.2016.02.002","volume":"1865","author":"F Mendes","year":"2016","unstructured":"Mendes F, Domingues C, Rodrigues-Santos P et al (2016) The role of immune system exhaustion on cancer cell escape and anti-tumor immune induction after irradiation. Biochim Biophys Acta \u2013 Rev Cancer 1865:168\u2013175. https:\/\/doi.org\/10.1016\/j.bbcan.2016.02.002","journal-title":"Biochim Biophys Acta \u2013 Rev Cancer"},{"key":"299-1_CR60","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41419-018-1285-3","volume":"10","author":"S Mohanty","year":"2019","unstructured":"Mohanty S, Yerneni K, Theruvath JL et al (2019) Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma. Cell Death Dis 10:36. https:\/\/doi.org\/10.1038\/s41419-018-1285-3","journal-title":"Cell Death Dis"},{"key":"299-1_CR61","doi-asserted-by":"publisher","first-page":"7730","DOI":"10.7150\/thno.37306","volume":"9","author":"S Mukherjee","year":"2019","unstructured":"Mukherjee S, Sonanini D, Maurer A, Daldrup-Link HE (2019) The yin and yang of imaging tumor associated macrophages with PET and MRI. Theranostics 9:7730\u20137748","journal-title":"Theranostics"},{"key":"299-1_CR62","first-page":"399","volume":"12","author":"M Murar","year":"2022","unstructured":"Murar M, Albertazzi L, Pujals S (2022) Advanced optical imaging-guided Nanotheranostics toward personalized cancer drug delivery. Nano 12:399","journal-title":"Nano"},{"key":"299-1_CR63","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.3389\/fimmu.2021.706583","volume":"12","author":"DM Murphy","year":"2021","unstructured":"Murphy DM, Mills KHG, Basdeo SA (2021) The effects of trained innate immunity on T cell responses; clinical implications and knowledge gaps for future research. Front Immunol 12:3306","journal-title":"Front Immunol"},{"key":"299-1_CR64","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.3389\/fimmu.2020.583084","volume":"11","author":"Y Pan","year":"2020","unstructured":"Pan Y, Yu Y, Wang X, Zhang T (2020) Tumor-associated macrophages in tumor immunity. Front Immunol 11:3151. https:\/\/doi.org\/10.3389\/fimmu.2020.583084","journal-title":"Front Immunol"},{"key":"299-1_CR65","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s10875-011-9532-8","volume":"31","author":"AC Parente-Pereira","year":"2011","unstructured":"Parente-Pereira AC, Burnet J, Ellison D et al (2011) Trafficking of CAR-engineered human T cells following regional or systemic adoptive transfer in SCID beige mice. J Clin Immunol 31:710\u2013718. https:\/\/doi.org\/10.1007\/s10875-011-9532-8","journal-title":"J Clin Immunol"},{"doi-asserted-by":"publisher","unstructured":"Pataskar A, Champagne J, Nagel R et al (2022) Tryptophan depletion results in tryptophan-to-phenylalanine substitutants. Nature 1\u20137. https:\/\/doi.org\/10.1038\/s41586-022-04499-2","key":"299-1_CR66","DOI":"10.1038\/s41586-022-04499-2"},{"doi-asserted-by":"publisher","unstructured":"Peng J, Xiao Y, Li W et al (2018) Photosensitizer micelles together with IDO inhibitor enhance cancer Photothermal therapy and immunotherapy. Adv Sci 5. https:\/\/doi.org\/10.1002\/advs.201700891","key":"299-1_CR67","DOI":"10.1002\/advs.201700891"},{"key":"299-1_CR68","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fmed.2020.00034","volume":"7","author":"J Perrin","year":"2020","unstructured":"Perrin J, Capitao M, Mougin-Degraef M et al (2020) Cell tracking in cancer immunotherapy. Front Med 7:34","journal-title":"Front Med"},{"doi-asserted-by":"publisher","unstructured":"Poon MML, Farber DL (2020) The whole body as the system in systems immunology. iScience 23:101509. https:\/\/doi.org\/10.1016\/j.isci.2020.101509","key":"299-1_CR69","DOI":"10.1016\/j.isci.2020.101509"},{"doi-asserted-by":"publisher","unstructured":"Pradeu T, Cooper EL (2012) The danger theory: 20 years later. Front Immunol 3. https:\/\/doi.org\/10.3389\/fimmu.2012.00287","key":"299-1_CR70","DOI":"10.3389\/fimmu.2012.00287"},{"key":"299-1_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtadv.2020.100087","volume":"8","author":"R Prasad","year":"2020","unstructured":"Prasad R, Jain NK, Conde J, Srivastava R (2020) Localized nanotheranostics: recent developments in cancer nanomedicine. Mater Today Adv 8:100087","journal-title":"Mater Today Adv"},{"key":"299-1_CR72","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MNM.0b013e3282f3a515","volume":"29","author":"A Rahmim","year":"2008","unstructured":"Rahmim A, Zaidi H (2008) PET versus SPECT: strengths, limitations and challenges. Nucl Med Commun 29:193\u2013207. https:\/\/doi.org\/10.1097\/MNM.0b013e3282f3a515","journal-title":"Nucl Med Commun"},{"key":"299-1_CR73","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1053\/j.semnuclmed.2009.12.004","volume":"40","author":"S Reddy","year":"2010","unstructured":"Reddy S, Robinson MK (2010) Immuno-positron emission tomography in cancer models. Semin Nucl Med 40:182\u2013189","journal-title":"Semin Nucl Med"},{"key":"299-1_CR74","doi-asserted-by":"publisher","first-page":"431","DOI":"10.7150\/ntno.55165","volume":"5","author":"A Rivera-Rodriguez","year":"2021","unstructured":"Rivera-Rodriguez A, Hoang-Minh LB, Chiu-Lam A et al (2021) Tracking adoptive t cell immunotherapy using magnetic particle imaging. Nano 5:431\u2013444. https:\/\/doi.org\/10.7150\/ntno.55165","journal-title":"Nano"},{"key":"299-1_CR75","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40364-022-00378-0","volume":"10","author":"K Sankar","year":"2022","unstructured":"Sankar K, Ye JC, Li Z et al (2022) The role of biomarkers in personalized immunotherapy. Biomark Res 10:32. https:\/\/doi.org\/10.1186\/s40364-022-00378-0","journal-title":"Biomark Res"},{"key":"299-1_CR76","doi-asserted-by":"publisher","first-page":"9054","DOI":"10.7150\/thno.62479","volume":"11","author":"P Sarbadhikary","year":"2021","unstructured":"Sarbadhikary P, George BP, Abrahamse H (2021) Recent advances in photosensitizers as multifunctional theranostic agents for imaging-guided photodynamic therapy of cancer. Theranostics 11:9054\u20139088","journal-title":"Theranostics"},{"doi-asserted-by":"publisher","unstructured":"Senapati S, Mahanta AK, Kumar S, Maiti P (2018) Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther 3:7. https:\/\/doi.org\/10.1038\/s41392-017-0004-3","key":"299-1_CR77","DOI":"10.1038\/s41392-017-0004-3"},{"unstructured":"Sherkar K, Varghese S, Sumant O (2021) Cancer immunotherapy market size, industry analysis report 2030. Allied Mark Res A01913. https:\/\/www.alliedmarketresearch.com\/cancer-immunotherapy-market. Accessed 11 Mar 2022","key":"299-1_CR78"},{"key":"299-1_CR79","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.addr.2020.06.025","volume":"163\u2013164","author":"F Soetaert","year":"2020","unstructured":"Soetaert F, Korangath P, Serantes D et al (2020) Cancer therapy with iron oxide nanoparticles: agents of thermal and immune therapies. Adv Drug Deliv Rev 163\u2013164:65\u201383","journal-title":"Adv Drug Deliv Rev"},{"doi-asserted-by":"publisher","unstructured":"Stanton SE, Eary JF, Marzbani EA et al (2016) Concurrent SPECT\/PET-CT imaging as a method for tracking adoptively transferred T-cells in vivo. J Immunother Cancer 4. https:\/\/doi.org\/10.1186\/s40425-016-0131-3","key":"299-1_CR80","DOI":"10.1186\/s40425-016-0131-3"},{"key":"299-1_CR81","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1021\/acs.accounts.7b00619","volume":"51","author":"SK Sun","year":"2018","unstructured":"Sun SK, Wang HF, Yan XP (2018) Engineering persistent luminescence nanoparticles for biological applications: from biosensing\/bioimaging to Theranostics. Acc Chem Res 51:1131\u20131143. https:\/\/doi.org\/10.1021\/acs.accounts.7b00619","journal-title":"Acc Chem Res"},{"key":"299-1_CR82","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41401-020-0424-4","volume":"41","author":"B Sun","year":"2020","unstructured":"Sun B, Hyun H, Tao LL, Wang AZ (2020a) Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment. Acta Pharmacol Sin 41:970\u2013985","journal-title":"Acta Pharmacol Sin"},{"key":"299-1_CR83","doi-asserted-by":"publisher","first-page":"31700","DOI":"10.1021\/acsomega.0c04213","volume":"5","author":"W Sun","year":"2020","unstructured":"Sun W, Tang F, Cui JX, Lu ZL (2020b) Fluorescent nanoparticles for targeted tumor imaging and DNA tracking gene delivery in vitro\/in vivo. ACS Omega 5:31700\u201331705. https:\/\/doi.org\/10.1021\/acsomega.0c04213","journal-title":"ACS Omega"},{"doi-asserted-by":"publisher","unstructured":"Sun IC, Jo S, Dumani D et al (2021) Theragnostic glycol chitosan-conjugated gold nanoparticles for photoacoustic imaging of regional lymph nodes and delivering tumor antigen to lymph nodes. Nano 11. https:\/\/doi.org\/10.3390\/nano11071700","key":"299-1_CR84","DOI":"10.3390\/nano11071700"},{"key":"299-1_CR85","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"doi-asserted-by":"publisher","unstructured":"Tay ZW, Chandrasekharan P, Fellows BD et al (2021) Magnetic particle imaging: an emerging modality with prospects in diagnosis, targeting and therapy of cancer. Cancers (Basel) 13(21):5285. https:\/\/doi.org\/10.3390\/cancers13215285","key":"299-1_CR86","DOI":"10.3390\/cancers13215285"},{"key":"299-1_CR87","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3389\/fchem.2020.597806","volume":"8","author":"N Thakur","year":"2020","unstructured":"Thakur N, Thakur S, Chatterjee S et al (2020) Nanoparticles as smart carriers for enhanced cancer immunotherapy. Front Chem 8:1217","journal-title":"Front Chem"},{"key":"299-1_CR88","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1021\/acsomega.8b03283","volume":"4","author":"G Thomas","year":"2019","unstructured":"Thomas G, Boudon J, Maurizi L et al (2019) Innovative magnetic nanoparticles for PET\/MRI bimodal imaging. ACS Omega 4:2637\u20132648. https:\/\/doi.org\/10.1021\/acsomega.8b03283","journal-title":"ACS Omega"},{"key":"299-1_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms4097","volume":"5","author":"DLJ Thorek","year":"2014","unstructured":"Thorek DLJ, Ulmert D, Diop NFM et al (2014) Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET\/MRI nanoparticle. Nat Commun 5:1\u20139. https:\/\/doi.org\/10.1038\/ncomms4097","journal-title":"Nat Commun"},{"key":"299-1_CR90","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.1039\/C9NR00242A","volume":"11","author":"A Tomitaka","year":"2019","unstructured":"Tomitaka A, Ota S, Nishimoto K et al (2019) Dynamic magnetic characterization and magnetic particle imaging enhancement of magnetic-gold core-shell nanoparticles. Nanoscale 11:6489\u20136496. https:\/\/doi.org\/10.1039\/C9NR00242A","journal-title":"Nanoscale"},{"key":"299-1_CR91","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41565-019-0567-y","volume":"14","author":"R van der Meel","year":"2019","unstructured":"van der Meel R, Sulheim E, Shi Y et al (2019) Smart cancer nanomedicine. Nat Nanotechnol 14:1007\u20131017. https:\/\/doi.org\/10.1038\/s41565-019-0567-y","journal-title":"Nat Nanotechnol"},{"doi-asserted-by":"publisher","unstructured":"van Leent MMT, Priem B, Schrijver DP et al (2022) Regulating trained immunity with nanomedicine. Nat Rev Mater 7:465\u2013481. https:\/\/doi.org\/10.1038\/s41578-021-00413-w","key":"299-1_CR92","DOI":"10.1038\/s41578-021-00413-w"},{"key":"299-1_CR93","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev-bioeng-071114-040723","volume":"17","author":"JJ Vaquero","year":"2015","unstructured":"Vaquero JJ, Kinahan P (2015) Positron emission tomography: current challenges and opportunities for technological advances in clinical and preclinical imaging systems. Annu Rev Biomed Eng 17:385\u2013414. https:\/\/doi.org\/10.1146\/annurev-bioeng-071114-040723","journal-title":"Annu Rev Biomed Eng"},{"key":"299-1_CR94","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41423-020-00530-6","volume":"18","author":"J Varad\u00e9","year":"2021","unstructured":"Varad\u00e9 J, Magad\u00e1n S, Gonz\u00e1lez-Fern\u00e1ndez \u00c1 (2021) Human immunology and immunotherapy: main achievements and challenges. Cell Mol Immunol 18:805\u2013828","journal-title":"Cell Mol Immunol"},{"key":"299-1_CR95","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3390\/ijms18050924","volume":"18","author":"M Vats","year":"2017","unstructured":"Vats M, Mishra S, Baghini M et al (2017) Near infrared fluorescence imaging in nano-therapeutics and photo-thermal evaluation. Int J Mol Sci 18:924. https:\/\/doi.org\/10.3390\/ijms18050924","journal-title":"Int J Mol Sci"},{"key":"299-1_CR96","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman AD, Fritz JM, Lenardo MJ (2020) A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol 20:651\u2013668","journal-title":"Nat Rev Immunol"},{"key":"299-1_CR97","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.7150\/thno.16715","volume":"6","author":"S Wang","year":"2016","unstructured":"Wang S, Lin J, Wang T et al (2016) Recent advances in photoacoustic imaging for deep-tissue biomedical applications. Theranostics 6:2394\u20132413","journal-title":"Theranostics"},{"key":"299-1_CR98","doi-asserted-by":"publisher","first-page":"1706747","DOI":"10.1002\/adma.201706747","volume":"30","author":"M Wang","year":"2018","unstructured":"Wang M, Deng K, L\u00fc W et al (2018) Rational design of multifunctional Fe@\u03b3-Fe2O3 @H-TiO2 nanocomposites with enhanced magnetic and Photoconversion effects for wide applications: from Photocatalysis to imaging-guided Photothermal cancer therapy. Adv Mater 30:1706747. https:\/\/doi.org\/10.1002\/adma.201706747","journal-title":"Adv Mater"},{"key":"299-1_CR99","doi-asserted-by":"publisher","first-page":"1901690","DOI":"10.1002\/advs.201901690","volume":"6","author":"Z Wang","year":"2019","unstructured":"Wang Z, Zhang F, Shao D et al (2019) Janus nanobullets combine photodynamic therapy and magnetic hyperthermia to potentiate synergetic anti-metastatic immunotherapy. Adv Sci 6:1901690. https:\/\/doi.org\/10.1002\/advs.201901690","journal-title":"Adv Sci"},{"key":"299-1_CR100","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.1021\/acsami.9b22072","volume":"12","author":"M Wang","year":"2020","unstructured":"Wang M, Yang Q, Li M et al (2020) Multifunctional nanoparticles for multimodal imaging-guided low-intensity focused ultrasound\/Immunosynergistic retinoblastoma therapy. ACS Appl Mater Interfaces 12:5642\u20135657. https:\/\/doi.org\/10.1021\/acsami.9b22072","journal-title":"ACS Appl Mater Interfaces"},{"key":"299-1_CR101","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41578-021-00315-x","volume":"6","author":"J Wang","year":"2021","unstructured":"Wang J, Li Y, Nie G (2021a) Multifunctional biomolecule nanostructures for cancer therapy. Nat Rev Mater 6:766\u2013783","journal-title":"Nat Rev Mater"},{"key":"299-1_CR102","doi-asserted-by":"publisher","first-page":"2106884","DOI":"10.1002\/adfm.202106884","volume":"31","author":"R Wang","year":"2021","unstructured":"Wang R, Shi J, Song L et al (2021b) Sustained antitumor immunity based on persistent luminescence nanoparticles for cancer immunotherapy. Adv Funct Mater 31:2106884. https:\/\/doi.org\/10.1002\/adfm.202106884","journal-title":"Adv Funct Mater"},{"doi-asserted-by":"crossref","unstructured":"Winter H, Brown AL, Goforth AM (2018) Bismuth-based nano- and microparticles in X-ray contrast, radiation therapy, and radiation shielding applications. In: Bismuth \u2013 advanced applications and defects characterization. InTech, London","key":"299-1_CR103","DOI":"10.5772\/intechopen.76413"},{"key":"299-1_CR104","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1021\/acsnano.9b08133","volume":"14","author":"XY Wong","year":"2020","unstructured":"Wong XY, Sena-Torralba A, \u00c1lvarez-Diduk R et al (2020) Nanomaterials for Nanotheranostics: tuning their properties according to disease needs. ACS Nano 14:2585\u20132627","journal-title":"ACS Nano"},{"doi-asserted-by":"publisher","unstructured":"Wu J, Chen J, Feng Y et al (2020) An immune cocktail therapy to realize multiple boosting of the cancer-immunity cycle by combination of drug\/gene delivery nanoparticles. Sci Adv 6. https:\/\/doi.org\/10.1126\/sciadv.abc7828","key":"299-1_CR105","DOI":"10.1126\/sciadv.abc7828"},{"key":"299-1_CR106","doi-asserted-by":"publisher","first-page":"12148","DOI":"10.1021\/acsnano.9b06691","volume":"13","author":"C Xu","year":"2019","unstructured":"Xu C, Nam J, Hong H et al (2019) Positron emission tomography-guided photodynamic therapy with biodegradable mesoporous silica nanoparticles for personalized cancer immunotherapy. ACS Nano 13:12148\u201312161. https:\/\/doi.org\/10.1021\/acsnano.9b06691","journal-title":"ACS Nano"},{"key":"299-1_CR107","doi-asserted-by":"publisher","first-page":"7360","DOI":"10.7150\/thno.58413","volume":"11","author":"Y Xuan","year":"2021","unstructured":"Xuan Y, Guan M, Zhang S (2021) Tumor immunotherapy and multi-mode therapies mediated by medical imaging of nanoprobes. Theranostics 11:7360\u20137378. https:\/\/doi.org\/10.7150\/thno.58413","journal-title":"Theranostics"},{"key":"299-1_CR108","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1172\/JCI83871","volume":"125","author":"Y Yang","year":"2015","unstructured":"Yang Y (2015) Cancer immunotherapy: harnessing the immune system to battle cancer. J Clin Invest 125:3335\u20133337","journal-title":"J Clin Invest"},{"key":"299-1_CR109","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3389\/fbioe.2019.00320","volume":"7","author":"Y Yang","year":"2019","unstructured":"Yang Y, Wang L, Wan B et al (2019a) Optically active nanomaterials for bioimaging and targeted therapy. Front Bioeng Biotechnol 7:320","journal-title":"Front Bioeng Biotechnol"},{"key":"299-1_CR110","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/cbic.201800589","volume":"20","author":"X Yang","year":"2019","unstructured":"Yang X, Lovell JF, Zhang Y (2019b) Ingestible contrast agents for gastrointestinal imaging. Chembiochem 20:462\u2013473. https:\/\/doi.org\/10.1002\/cbic.201800589","journal-title":"Chembiochem"},{"key":"299-1_CR111","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrclinonc.2016.212","volume":"14","author":"RR Zhang","year":"2017","unstructured":"Zhang RR, Schroeder AB, Grudzinski JJ et al (2017) Beyond the margins: real-time detection of cancer using targeted fluorophores. Nat Rev Clin Oncol 14:347\u2013364","journal-title":"Nat Rev Clin Oncol"},{"key":"299-1_CR112","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1021\/acs.nanolett.8b04296","volume":"19","author":"YX Zhang","year":"2019","unstructured":"Zhang YX, Zhao YY, Shen J et al (2019) Nanoenabled modulation of acidic tumor microenvironment reverses Anergy of infiltrating T cells and potentiates anti-PD-1 therapy. Nano Lett 19:2774\u20132783. https:\/\/doi.org\/10.1021\/acs.nanolett.8b04296","journal-title":"Nano Lett"},{"key":"299-1_CR113","volume":"2","author":"P Zhang","year":"2021","unstructured":"Zhang P, Meng J, Li Y et al (2021a) Nanotechnology-enhanced immunotherapy for metastatic cancer. Innov 2:100174","journal-title":"Innov"},{"key":"299-1_CR114","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12951-021-00870-z","volume":"19","author":"N-N Zhang","year":"2021","unstructured":"Zhang N-N, Lu CY, Jiang CM et al (2021b) Recent advances in near-infrared II imaging technology for biological detection. J Nanobiotechnol 19:132","journal-title":"J Nanobiotechnol"},{"key":"299-1_CR115","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bioactmat.2020.08.024","volume":"6","author":"X Zhang","year":"2021","unstructured":"Zhang X, Tang J, Li C et al (2021c) A targeting black phosphorus nanoparticle based immune cells nano-regulator for photodynamic\/photothermal and photo-immunotherapy. Bioact Mater 6:472\u2013489. https:\/\/doi.org\/10.1016\/j.bioactmat.2020.08.024","journal-title":"Bioact Mater"},{"key":"299-1_CR116","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12951-021-00880-x","volume":"19","author":"L Zhang","year":"2021","unstructured":"Zhang L, Zhang J, Xu L et al (2021d) NIR responsive tumor vaccine in situ for photothermal ablation and chemotherapy to trigger robust antitumor immune responses. J Nanobiotechnol 19:142. https:\/\/doi.org\/10.1186\/s12951-021-00880-x","journal-title":"J Nanobiotechnol"},{"key":"299-1_CR117","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E (2020) Interaction between microbiota and immunity in health and disease. Cell Res 30:492\u2013506","journal-title":"Cell Res"},{"key":"299-1_CR118","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s41587-019-0262-4","volume":"37","author":"Y Zhong","year":"2019","unstructured":"Zhong Y, Ma Z, Wang F et al (2019) In vivo molecular imaging for immunotherapy using ultra-bright near-infrared-IIb rare-earth nanoparticles. Nat Biotechnol 37:1322\u20131331. https:\/\/doi.org\/10.1038\/s41587-019-0262-4","journal-title":"Nat Biotechnol"},{"key":"299-1_CR119","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.1039\/C6CS00271D","volume":"45","author":"Z Zhou","year":"2016","unstructured":"Zhou Z, Song J, Nie L, Chen X (2016) Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy. Chem Soc Rev 45:6597\u20136626","journal-title":"Chem Soc Rev"},{"key":"299-1_CR120","doi-asserted-by":"publisher","first-page":"10723","DOI":"10.1021\/acsomega.1c00225","volume":"6","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, Xie J, Ma S et al (2021) Construction of smart Nanotheranostic platform bi-ag@PVP: multimodal CT\/PA imaging-guided PDT\/PTT for cancer therapy. ACS Omega 6:10723\u201310734. https:\/\/doi.org\/10.1021\/acsomega.1c00225","journal-title":"ACS Omega"},{"doi-asserted-by":"publisher","unstructured":"Zhu Q, Sun F, Li T et al (2021) Engineering Oxaliplatin prodrug nanoparticles for second near-infrared fluorescence imaging-guided immunotherapy of colorectal cancer. Small 17. https:\/\/doi.org\/10.1002\/smll.202007882","key":"299-1_CR121","DOI":"10.1002\/smll.202007882"},{"key":"299-1_CR122","doi-asserted-by":"publisher","first-page":"7471","DOI":"10.7150\/thno.59953","volume":"11","author":"S Zuo","year":"2021","unstructured":"Zuo S, Song J, Zhang J et al (2021) Nano-immunotherapy for each stage of cancer cellular immunity: which, why, and what? Theranostics 11:7471\u20137487. https:\/\/doi.org\/10.7150\/thno.59953","journal-title":"Theranostics"}],"container-title":["Handbook of Cancer and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-80962-1_299-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T15:26:31Z","timestamp":1725549991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-80962-1_299-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783030809621","9783030809621"],"references-count":122,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-80962-1_299-1","relation":{},"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"5 August 2022, 00:00:00","order":1,"name":"received","label":"Received","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"6 August 2022, 00:00:00","order":2,"name":"accepted","label":"Accepted","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"11 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}